“Morphologic leukemia-free state after venetoclax-based therapy in acute myeloid leukemia is associated with high relapse despite preserved short-term survival”, Mediterr J Hematol Infect Dis, vol. 18, no. 1, p. e2026048, Apr. 2026, doi: 10.4084/MJHID.2026.048.